OTCBB:BTCY
Biotricity Inc Stock News
$1.25
-0.0522 (-4.01%)
At Close: May 03, 2024
Biotricity (BTCY) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
10:56am, Thursday, 04'th Apr 2024
After losing some value lately, a hammer chart pattern has been formed for Biotricity (BTCY), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revi
Here Is Why Bargain Hunters Would Love Fast-paced Mover Biotricity Inc. (BTCY)
09:51am, Thursday, 14'th Mar 2024
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Biotricity Inc. (BTCY) could be a great choice. It is one of the several stocks that
Biotricity Inc. (BTCY) Upgraded to Buy: Here's What You Should Know
01:01pm, Thursday, 07'th Mar 2024
Biotricity Inc. (BTCY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Biotricity Inc. (BTCY) Reports Q3 Loss, Misses Revenue Estimates
07:21pm, Tuesday, 20'th Feb 2024
Biotricity Inc. (BTCY) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to loss of $0.54 per share a year ago.
Biotricity to Host Third Quarter Fiscal Year 2024 Financial Results and Business Update Call on February 21st
08:00am, Monday, 19'th Feb 2024
REDWOOD CITY, CA / ACCESSWIRE / February 19, 2024 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sect
Company continues its shift to subscription-based revenue, prioritizing margin improvement and operational efficiency enhancements, on the path to breakeven Management to announce Third Quarter Fiscal
Biotricity, Inc. (BTCY) Q2 2024 Earnings Call Transcript
09:25pm, Tuesday, 14'th Nov 2023
Biotricity, Inc. (NASDAQ:BTCY ) Q2 2024 Earnings Conference Call November 14, 2023 6:00 PM ET Company Participants Debra Chen - IR Waqaas Al-Siddiq - Founder and CEO John Ayanoglou - CFO Conference Ca
Biotricity to Host Second Quarter Fiscal Year 2024 Financial Results and Business Update Call on November 14th
09:30am, Friday, 10'th Nov 2023
Biotricity improves margins while lowering selling expenses and operating losses REDWOOD CITY, CA / ACCESSWIRE / November 10, 2023 / Biotricity Inc. (Nasdaq:BTCY) ("Biotricity" or the "Company"), a Te
Biotricity (BTCY) Q1 2024 Earnings Call Transcript
09:13pm, Tuesday, 15'th Aug 2023
Biotricity (NASDAQ:BTCY ) Q1 2024 Earnings Conference Call August 15, 2023 4:30 PM ET Company Participants Debra Chen – Investor Relations Waqaas Al-Siddiq – Founder and Chief Executive Officer Jo
Biotricity to Host First Quarter Fiscal Year 2024 Financial Results and Business Update Call on August 15th
08:15am, Monday, 14'th Aug 2023
REDWOOD CITY, CA / ACCESSWIRE / August 14, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector
Biotricity's Founder & CEO Waqaas Al-Siddiq to Present at World Heart Summit May 19-21 in Geneva, Switzerland
08:30am, Wednesday, 10'th May 2023
Dr. Waqaas will address, meet with, world leaders and medical innovators on pressing challenges and solutions in global cardiovascular health, digital health and AI REDWOOD CITY, CA / ACCESSWIRE / May
Biotricity, Inc. (BTCY) Q3 2023 Earnings Call Transcript
06:20pm, Tuesday, 14'th Feb 2023
Biotricity, Inc. (NASDAQ:BTCY ) Q3 2023 Earnings Conference Call February 14, 2023 4:30 PM ET Company Participants Debra Chen - Investor Relations Waqaas Al-Siddiq - Founder & Chief Executive Officer
Biotricity To Host Fiscal 2023 Third Quarter Financial Results Call on February 14th at 4:30pm ET
08:00am, Thursday, 09'th Feb 2023
REDWOOD CITY, CA / ACCESSWIRE / February 9, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today announced it wi
REDWOOD CITY, CA / ACCESSWIRE / February 3, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, is excited to announc
REDWOOD CITY, CA / ACCESSWIRE / January 23, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, announced today that
